The American Cancer Society has updated its colorectal cancer screening recommendations to include new blood and stool-based ...

The American Cancer Society updated its colorectal cancer screening guidelines to include additional blood- and stool-based screening options, while reaffirming that average-risk adults should begin ...

Updated ACS guidance suggests use in those who decline other options ...

ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, announced the publication of a ...

New recommendations from the American Cancer Society include blood-based and updated at-home tests as colon cancer screening ...

Please provide your email address to receive an email when new articles are posted on . Previously granted FDA breakthrough device designation in January 2020, ColoSense is the “first noninvasive ...

The NCCN Guidelines are comprehensive, evidence-based recommendations to support the prevention, diagnosis, and treatment of more than 97% of cancers affecting patients in the United States. They are ...

Colonoscopies are still the gold standard, but experts now endorse a high-tech stool test and a blood draw amid rising rates ...

Geneoscopy’s ColoSense® is now an American Cancer Society-preferred at-home RNA test for colorectal cancer screening in ...

At-home colon cancer tests typically involve mailing in a self-collected stool sample, though each type of test follows a ...

A stool test is a diagnostic procedure that involves analyzing fecal matter, or poop, to check for signs of infection, inflammation, or disease. The specific analysis depends on a person’s symptoms ...